Post menopausal women receiving hormone replacement therapy (HRT) combining estrogen and progestin have an increased risk of getting breast cancer and dying of breast cancer. HRT also interferes with the early detection of breast cancer.
Less than 25% of patients diagnosed with triple-negative breast cancer are able to be treated successfully with chemotherapy. Researchers in Detroit at the Karmanos Cancer Institute have received nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study immunotherapy treatment for triple-negative breast cancer.
Among the many damages caused by breast cancer are sexual side effects. A study now shows that 70% of women who have had breast cancer suffer from sexual problems as a result.
Cancer researchers have a new tool to predict recurrence of ductal in situ breast cancer. This tool can generate an individualized estimate of the patient's risk of cancer recurrence and help the patient weigh the risks and benefits of post-surgical treatment options which include radiation and hormone therapy.
A study comparing breast cancer rates in North America and South America shows a much lower incidence of breast cancer in South American countries such as Brazil compared to the United States, and links the result to healther body weight, lower alcohol consumption, exercise, and even breast feeding.
Avastin received accelerated approval to treat breast cancer from the FDA, but now experts have found that treating breast cancer with chemotherapy versus treating with chemotherapy plus Avastin is not clinically different.
Updated guidelines recommend consideration of aromatase inhibitors at some point for all postmenopausal women with hormone receptor-positive breast cancer, though not for more than five years. The updated guidelines do not apply to pre-menopausal or peri-menopausal women.
The newly published study out of Seattle suggests that taking fish oil capsules may be linked to a more than 32% decrease in risk of ductal breast cancer but cautions that further studies on the causal link are needed before it can be recommended.
Research has found that a substance found in certain foods including broccoli and brussels sprouts inhibits the growth of breast cancer cells. Treatment for breast cancer may include nutritional therapies this study suggest. If you have legal questions about your breast cancer diagnosis or treatment, get in touch with us at the Pittsburgh law firm Berger & Lagnese P.C.
For some breast cancers where the sentinel lymph node tests positive, new study suggests removing axillary nodes does not increase survival rate after 6 years.
The FDA has approved the use of Tykerb (lapatinib) in combination with Femara (letrozole) for postmenopausal women with breast cancer. For free information about breast cancer, contact the breast cancer medical malpractice attorneys of Pittsburgh, Pennsylvania.
A report has found that a unique massage technique, physiotherapy, can stop lymphedema from developing in some women when performed after breast cancer surgery that involves dissection of certain lymph nodes.
For more free information about breast cancer, contact the breast cancer attorneys of Pittsburgh, Pennsylvania.
Breast cancer is a deadly disease. But if if it diagnosed early, you can be cured. The failure to diagnose breast cancer may be medical malpractice. This blog discusses the treatment of women with breast cancer that has spread. A study shows that Avastin can improve survival for these women.
Mammograms can find your breast cancer, but only if they are done and interpreted accurately. The failure to order mammograms or to miss cancer on a mammogram may be medical malpractice. The American College of Radiology recommends annual mammograms beginning at age 40 for average risk women, and those with high risk of breast cancer should have mammograms and MRI beginning at age 30.
If your breast cancer was missed, or not timely and properly diagnosed or treated, you have come to the right place. Our attorneys specialize in breast cancer cases.
According to a report by the American Institute for Cancer Research, women can cut their risk of breast cancer by at least 40% if they take some preventative steps. The researchers looked at links between breast cancer and diet, body weight and physical activity.
The recent study is an update from a 2007 review of more than 800 studies. However, the newly updated review includes evidence from an additional 81 studies that have been published since then.
The report on breast cancer is part of the Continuous Update Project. The long-term goal is to continuously update the findings of the expert report so that cancer prevention advice is always based on the latest research.
According to a recent study which was published in a journal for the American Association for Cancer Research, metabolic syndrome may play a role in the risk of postmenopausal breast cancer.
Metabolic syndrome, or insulin resistance syndrome, is characterized by abdominal obesity, high blood glucose levels, impaired glucose tolerance, dyslipidemia, and hypertension. It can also increase the risk for diabetes and coronary heart disease.
In this study, the researchers used existing data from the Women's Health Initiative. Participants included postmenopausal women aged 50 to 79 years at enrollment who had repeated measurements of components of metabolic syndrome over an eight-year period. The results of the study suggest an association between having the metabolic syndrome and an increased risk of postmenopausal breast cancer.
To date, studies have evaluated individual components of the metabolic syndrome and breast cancer, however, this is the first time researchers have assessed whether women who met the criteria of having the metabolic syndrome were at greater risk for postmenopausal breast cancer.
It is known that Vitamin D deficiency is associated with increased risk of breast cancer and decreased survival. A new study quantified the prevalence of Vitamin D deficiency in women with breast cancer. This study, from physicians at Columbia University, found that 74% of women with breast cancer were Vitamin D deficient. They prescribed vitamin D and calcium carbonate for one year but only 15% were able to achieve normal vitamin D levels. Optimal dosing for bone health is still unknown This study was supported by the NationalCancer Institute and published in the Journal of Clinical Oncology.
In a study published in Cancer, nearly 20% of women with breast cancer who would benefit from radiation after mastectomy, also known as post-mastectomy radiation treatment (PMRT), are not receiving the treatment.
The researchers surveyed the women and assessed the rates of explanation, recommendation, and utilization of PMRT based on the ASCO guidelines. The study found that radiation delivered after a mastectomy has been shown to reduce the risk of cancer returning in the chest wall and improve survival in high-risk patients.
As reported in the March 24 online edition of the journal Clinical Cancer Research, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have identified a new marker for breast cancer metastasis called TMEM, for Tumor Microenvironment of Metastasis. According to the new research, density of TMEM is associated with the development of distant organ metastasis via the bloodstream -- the most common cause of death from breast cancer. This research may lead to the first test to predict the likelihood of breast cancer metastasis via the bloodstream, and ultimately to changes the way breast cancer is treated.
An estimated 40 percent of all breast cancer patients relapse and develop metastatic disease. Traditionally, the likelihood of breast cancer metastasis is estimated based on tumor size, tumor differentiation -- how similar or dissimilar the tumor is compared to normal breast tissue -- and whether the cancer has spread to the lymph nodes. TMEM density may prove to be more determinative of the likelihood of breast cancer metastatis than these traditional measures.
If your breast cancer was missed or misdiagnosed, see the breast cancer malpractice lawyers of Pennsylvania. Berger & Lagnese is a law firm that specializes in breast cancer medical malpracticecases. We work on cases in Pittsburgh and all over Western Pennsylvania, including Greensburg, Washington, Uniontown, Beaver, and Erie.
A new study published in the open access journal Breast Cancer Research has found that black women face three times the risk of developing an aggressive "triple negative tumor" breast cancer compared to women of other racial backgrounds. Triple negative tumors are breast cancer tumors that lack expression of the estrogen receptor, the progesterone receptor, and the HER2 gene.
The United States has the highest rate of breast cancer in the world. The overall incidence of breast cancer in the United States is lower in black women than in white women; however, according to the new study, when black women do get breast cancer, their cancer tends to be more advanced when diagnosed, has a higher risk or recurring, and a less favorable outcome.
If your breast cancer was missed or misdiagnosed, see the breast cancer malpractice lawyers of Pennsylvania. Berger & Lagnese is a law firm that specializes in breast cancer medical malpracticecases. We work on cases in Pittsburgh and all over Western Pennsylvania, including Greensburg, Washington, Uniontown, Beaver, and Erie.
For a medical malpractice attorney in Pittsburgh, PA, I recommend Joshua Berger. I had a heart surgery that injured me. Attorney Berger got me a great settlement, prepared me well, and his law firm was kind and caring.
Attorney Paul Lagnese "He Understood"
The lawyers at Berger & Lagnese treated me with dignity and respect.
Attorney Josh Berger Recommended For Death of Man After Carotid Artery Surgery
Attorney David Paul reccomended for his outstanding job!
Attorney Paul Lagnese Recommended for Medical Malpractice Cases in Pittsburgh, Pennsylvania